Canavan disease is a progressive metabolic neurological disease with developmental delays by the age of three to five months, and muscle weakness which eventually changes to spasticity. Life expectancy is usually into the teens. Mutations in ASPA, the gene encoding the enzyme aspartoacylase, are more common in Ashkenazi Jewish persons. Canavan disease is inherited in an autosomal recessive manner.